A clinical trial has begun which will use stem cell transplants to grow a new immune system for people with untreatable Crohn’s disease – a painful and chronic intestinal disease which affects at least 115,000 people in the UK.
The study, led by Queen Mary University of London and Barts Health NHS Trust, is funded with £2m from a Medical Research Council and National Institute for Health Research partnership, and will be recruiting patients from centres in Cambridge, Edinburgh, Liverpool, London, Nottingham, Oxford and Sheffield. The trial is coordinated through the Clinical Trials Unit at the University of Sheffield.
Crohn’s disease is a long-term condition that causes inflammation of the lining of the digestive system, and results in diarrhoea, abdominal pain, extreme tiredness and other symptoms that significantly affect quality of life.
Current treatments include drugs to reduce inflammation but these have varying results, and surgery is often needed to remove the affected part of the bowel. In extreme cases, after multiple operations over the years, patients may require a final operation to divert the bowel from the anus to an opening in the stomach, called a stoma, where stools are collected in a pouch.
‘We might be able to radically alter the course of the disease’
Chief investigator Professor James Lindsay from Queen Mary’s Blizard Institute and a consultant at Barts Health NHS Trust said: “Despite the introduction of new drugs, there are still many patients who don’t respond, or gradually lose response, to all available treatments. Although surgery with the formation of a stoma may be an option that allows patients to return to normal daily activities, it is not suitable in some and others may not want to consider this approach.
“We’re hoping that by completely resetting the patient’s immune system through a stem cell transplant, we might be able to radically alter the course of the disease. While it may not be a cure, it may allow some patients to finally respond to drugs which previously did not work.”
Helen Bartlett, a Crohn’s disease patient who had stem cell therapy at John Radcliffe Hospital, Oxford, said: “Living with Crohn’s is a daily struggle. You go to the toilet so often, you bleed a lot and it’s incredibly tiring. You also always need to be careful about where you go. I’ve had to get off trains before because there’s been no toilet, and I needed to go there and then.
“I’ve been in and out of hospital for the last twenty years, operation after operation, drug after drug, to try to beat this disease. It’s frustrating, it’s depressing and you just feel so low.
“When offered the stem cell transplant, it was a complete no brainer as I didn’t want to go through yet more failed operations. I cannot describe how much better I feel since the treatment. I still have problems and I’m always going to have problems, but I’m not in that constant pain.”
Giving patients a new immune system
The Latest on: Crohn’s disease
via Google News
The Latest on: Crohn’s disease
- AbbVie says CMHP recommends European approval of Risankizumab for treatment of Crohn's diseaseon September 19, 2022 at 1:43 am
AbbVie secures positive CHMP opinion for Risankizumab (SKYRIZI) for the treatment of adults with moderate to severe Crohn's disease. Europe European Medicines Agency AbbVie announced the European ...
- AbbVie Receives CHMP Positive Opinion For Skyrizi For Moderate To Severe Crohn's Diseaseon September 19, 2022 at 12:22 am
AbbVie Inc. (ABBV) said on Monday that the Committee for Medicinal Products for Human Use has adopted positive opinion to extend the indication of Skyrizi for the treatment of adults with moderate to ...
- AbbVie Secures Positive CHMP Opinion for Risankizumab (SKYRIZI®) for the Treatment of Adults with Moderate to Severe Crohn's Diseaseon September 18, 2022 at 11:00 pm
AbbVie (NYSE: ABBV) today announced the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CMHP) adopted a positive opinion recommending the approval of risankizumab ...
- Can Medical Marijuana Improve Crohn’s Disease Symptoms?on September 16, 2022 at 1:59 pm
While some evidence suggests that cannabis use may help relieve Crohn’s symptoms, more research is needed to show disease improvement. Here’s what you should know before you give it a try.
- Kids Day: Maeve Garvey battles Crohn's disease with grit and determinationon September 16, 2022 at 4:00 am
"We know that a lot of people travel to Rochester or even New York City or Cleveland to seek out pediatric GI specialists, but we really hit the jackpot right here in Buffalo," her mother said.
- Cannock woman found out she had leukaemia during Crohn's check-upon September 15, 2022 at 3:53 am
A woman from Cannock who went for a check-up for Crohn's disease was floored when she was diagnosed with leukaemia.
- Crohn’s Disease Market to Record a CAGR of 7.6%, North America to Contribute Majority of Industry Growth: Market.uson September 15, 2022 at 1:46 am
Pune, Maharashtra, India, September 15 2022 (Wiredrelease) Prudour Pvt. Ltd –:Crohn’s disease is a type of inflammatory bowel disease that can affect any part of the gastrointestinal tract. Symptoms ...
- Student who blamed ‘too much partying’ for her vomiting and diarrhoea given unexpected diagnosison September 14, 2022 at 12:16 am
A university student who put her vomiting and diarrhoea down to boy troubles and excessive partying only discovered she had Crohn’s disease after her bowel nearly perforated. And when Lucy ...
- 'Exciting new treatment for Crohn's patients who haven’t responded to previous therapy'on September 11, 2022 at 6:53 am
Treatment for Crohn's typically involves anti-inflammatory drugs, anti-diarrhoea medication and stronger medicines called biologics that suppress the immune response, Dr Miriam Stoppard says ...
via Bing News